Loading insider details...
Beta
Latest Form 4 (Aug 12, 2026): Exercise/Conversion of 800 REGN shares, $301.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 12, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 800 | $301.4K |
| Feb 23, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 1,638 | $617.0K |
| Jan 6, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 155 | n/a |
| Jan 6, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 166 | n/a |
| Jan 4, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 1,117 | $437.8K |
| Oct 17, 2023 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 1,000 | $391.9K |
| Jan 5, 2023 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 165 | n/a |
| Mar 18, 2022 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 2,000 | $783.8K |
| Jan 5, 2022 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 191 | n/a |
| Sep 15, 2021 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 2 | $783.84 |